Celldex Therapeutics, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2020
Total Assets: $235.8M
Liabilities Breakdown FY2020
Total Liabilities: $26.5M
Asset Breakdown
Total Assets: $235.8M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $43.8M | 18.6% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $3.8M | 1.6% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $30.7M | 13.0% |
| Other Assets | $157.5M | 66.8% |
Liabilities Breakdown
Total Liabilities: $26.5M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.0M | 4.0% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $25.4M | 96.0% |